Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.George Yaghmour, Michael G. Martin, Scott Baum et al.|PubMed|2016Cited by 29
Role of genomic instability in immunotherapy with checkpoint inhibitors.George Yaghmour, Michael G. Martin, Manjari Pandey et al.|Journal of Clinical Oncology|2016Cited by 16
Impact of Provider Volume on Outcomes of Patients With Hodgkin LymphomaCatherine G. Ireland, Mike G. Martin, George Yaghmour et al.|World Journal of Oncology|2018Cited by 5